Levetiracetam and Bleeding into the skin - a phase IV clinical study of FDA data
Bleeding into the skin is found among people who take Levetiracetam, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Levetiracetam and have Bleeding into the skin. It is created by eHealthMe based on reports of 60,115 people who have side effects when taking Levetiracetam from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
60,115 people reported to have side effects when taking Levetiracetam.
Among them, 90 people (0.15%) have Bleeding into the skin.
What is Levetiracetam?
Levetiracetam has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 60,619 Levetiracetam users for its effectiveness, alternative drugs and more.
What is Bleeding into the skin?
Bleeding into the skin is found to be associated with 2,171 drugs and 1,718 conditions by eHealthMe.
Number of Levetiracetam and Bleeding into the skin reports submitted per year:
Time on Levetiracetam when people have Bleeding into the skin *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Bleeding into the skin when taking Levetiracetam *:
- female: 63.53 %
- male: 36.47 %
Age of people who have Bleeding into the skin when taking Levetiracetam *:
- 0-1: 1.2 %
- 2-9: 13.25 %
- 10-19: 14.46 %
- 20-29: 7.23 %
- 30-39: 13.25 %
- 40-49: 13.25 %
- 50-59: 9.64 %
- 60+: 27.71 %
Common drugs people take besides Levetiracetam *:
- Pradaxa: 12 people, 13.33%
- Amlodipine: 12 people, 13.33%
- Ondansetron: 6 people, 6.67%
- Keppra: 5 people, 5.56%
- Multaq: 5 people, 5.56%
- Lemtrada: 4 people, 4.44%
- Pantoprazole: 4 people, 4.44%
- Zofran: 3 people, 3.33%
- Promethazine: 3 people, 3.33%
- Carbamazepine: 3 people, 3.33%
Common side effects people have besides Bleeding into the skin *:
- Thrombocytopenia (decrease of platelets in blood): 33 people, 36.67%
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 17 people, 18.89%
- Haematoma (collection of blood outside the blood vessels): 17 people, 18.89%
- Nosebleed (bleeding from nose): 17 people, 18.89%
- Ecchymosis (a discoloration of the skin resulting from bleeding underneath): 14 people, 15.56%
- Weakness: 14 people, 15.56%
- Head Injury: 14 people, 15.56%
- Gingival Bleeding (bleeding gums): 12 people, 13.33%
- International Normalised Ratio Increased: 11 people, 12.22%
- Headache (pain in head): 11 people, 12.22%
Common conditions people have *:
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 9 people, 10.00%
- Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 6 people, 6.67%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 4.44%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 3.33%
- Retroperitoneal Cancer (cancer between the peritoneum and the posterior abdominal wall): 3 people, 3.33%
- Brain Neoplasm Malignant (brain cancer tumour): 3 people, 3.33%
- Cerebral Palsy: 3 people, 3.33%
- Partial Seizures (seizures which affect only a part of the brain at onset): 3 people, 3.33%
- Ovarian Cancer (cancer of ovary): 3 people, 3.33%
- Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 3 people, 3.33%
* Approximation only. Some reports may have incomplete information.
Do you take Levetiracetam and have Bleeding into the skin?Check whether Bleeding into the skin is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
How severe was Bleeding into the skin and when was it recovered:
Expand to all the drugs that have ingredients of levetiracetam:
Alternative drugs to, pros and cons of Levetiracetam:
- Levetiracetam (60,619 reports)
Common Levetiracetam side effects:
Browse all side effects of Levetiracetam:a b c d e f g h i j k l m n o p q r s t u v w x y z
Bleeding into the skin treatments and more:
- Bleeding into the skin (13,575 reports)
COVID vaccines that are related to Bleeding into the skin:
- Bleeding into the skin in Moderna COVID Vaccine
- Bleeding into the skin in Pfizer BioNTech Covid Vaccine
- Bleeding into the skin in Johnson and Johnson Covid Vaccine
Common drugs associated with Bleeding into the skin:
All the drugs that are associated with Bleeding into the skin:
- Bleeding into the skin (2,171 drugs)
Common conditions associated with Bleeding into the skin:
All the conditions that are associated with Bleeding into the skin:
- Bleeding into the skin (1,718 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on levetiracetam (the active ingredients of Levetiracetam) and Levetiracetam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Calcium Lactate and Dehydration - 16 seconds ago
- Pravastatin Sodium and Axotal drug interaction - 26 seconds ago
- Dymista vs. Benadryl Preservative Free - 42 seconds ago
- Vasotec and Skin Necrosis - 44 seconds ago
- Isosorbide Dinitrate and Bumetanide drug interaction - 48 seconds ago
- Timolol Maleate and Blood Pressure Diastolic Decreased - 57 seconds ago
- Cyclophosphamide and Bladder Cancer - a minute ago
- Alendronic Acid and Lung Squamous Cell Carcinoma Stage Unspecified - a minute ago
- Curcumin and Lipitor drug interaction - a minute ago
- Ampyra and Allegra-D 12 Hour drug interaction - a minute ago